The past, present and future of antiviral drug discovery

被引:0
|
作者
Littler, E [1 ]
机构
[1] Medivir UK Ltd, Saffron Walden CB10 1XL, Essex, England
关键词
antiviral; drug discovery; emerging viruses; virus;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A review of the history, development and current status of antiviral chemotherapy is presented from its origins in the 1960s until the present day. Key issues in the development of novel antivirals are the emergence of resistant virus, safety and side effects. This review describes the current therapeutic status of the herpes viruses, HIV, hepatitis viruses and respiratory viruses, and outlines the current limitations in the field together with the future compounds likely to emerge to address these needs. The future of antiviral research is assessed in relation to the impact of potential 'emerging viruses' and biological weapons, and the potential of combination therapies involving antivirals and disease modification.
引用
收藏
页码:1104 / 1112
页数:9
相关论文
共 50 条
  • [1] Drug discovery: past, present and future
    Malik, Nafees N.
    [J]. DRUG DISCOVERY TODAY, 2008, 13 (21-22) : 909 - 912
  • [2] Drug discovery technology: The past, the present, and the future
    Lipinski, Chris
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [3] Bromodomain Drug Discovery - the Past, the Present, and the Future
    Pervaiz, Mehrosh
    Mishra, Pankaj
    Guenther, Stefan
    [J]. CHEMICAL RECORD, 2018, 18 (12): : 1808 - 1817
  • [4] Phenotypic screening in cancer drug discovery — past, present and future
    John G. Moffat
    Joachim Rudolph
    David Bailey
    [J]. Nature Reviews Drug Discovery, 2014, 13 : 588 - 602
  • [5] Phenotypic screening in cancer drug discovery - past, present and future
    Moffat, John G.
    Rudolph, Joachim
    Bailey, David
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (08) : 588 - 602
  • [6] Drug discovery: Past and present
    Giridhar, Rajani
    [J]. JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2012, 3 (01) : 2 - 2
  • [7] Drug discovery in ophthalmology: past success, present challenges, and future opportunities
    Gower, Nicholas J. D.
    Barry, Robert J.
    Edmunds, Matthew R.
    Titcomb, Lucy C.
    Denniston, Alastair K.
    [J]. BMC OPHTHALMOLOGY, 2016, 16
  • [8] NMR in integrated biophysical drug discovery for RAS: past, present, and future
    Marshall, Christopher B.
    KleinJan, Fenneke
    Gebregiworgis, Teklab
    Lee, Ki-Young
    Fang, Zhenhao
    Eves, Ben J.
    Liu, Ningdi F.
    Gasmi-Seabrook, Genevieve M. C.
    Enomoto, Masahiro
    Ikura, Mitsuhiko
    [J]. JOURNAL OF BIOMOLECULAR NMR, 2020, 74 (10-11) : 531 - 554
  • [9] Medicinal chemistry in drug discovery in big pharma: past, present and future
    Campbell, Ian B.
    Macdonald, Simon J. F.
    Procopiou, Panayiotis A.
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (02) : 219 - 234
  • [10] NMR in integrated biophysical drug discovery for RAS: past, present, and future
    Christopher B. Marshall
    Fenneke KleinJan
    Teklab Gebregiworgis
    Ki-Young Lee
    Zhenhao Fang
    Ben J. Eves
    Ningdi F. Liu
    Geneviève M. C. Gasmi-Seabrook
    Masahiro Enomoto
    Mitsuhiko Ikura
    [J]. Journal of Biomolecular NMR, 2020, 74 : 531 - 554